D-045
Today
2025.03.31
2025.03.31
Program
Scientific Program
- May 15(Thu)
- 09:00-10:30
- Year in Review, Clinical
- Room 1 (3F)
- Korean (AI Translation)
- 09:00-09:30
- Crystal arthropathy
- Yun Hong Cheon (Gyeongsang Nat'l Univ., Korea)
- 09:30-10:00
- Large vessel vasculitis
- Oh Chan Kwon (Yonsei Univ., Korea)
- 10:00-10:30
- IgG4-related disease
- Hyoun-ah Kim (Ajou Univ., Korea)
- May 15(Thu)
- 11:00-12:00
- Presidential Plenary Session
- Room 1 (3F)
- Korean (AI Translation)
- 11:00-11:30
- Innovating rheumatology: Bridging tradition and tomorrow
- Tae-Hwan Kim (Hanyang Univ., Korea)
- 11:30-12:00
- Navigating new frontiers in Korean rheumatology: A visionary's perspective
- Jung Soo Song (Chung-Ang Univ., Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 1 [Johnson&Johnson]
- Advancing RA Care: Practical Insight of Golimumab IV
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Chang Keun Lee (Univ. of Ulsan, Korea)
- 12:00-13:00
- Optimizing RA care with Golimumab IV: Clinical impact from the first dose
- So-Young Bang (Hanyang Univ., Korea)
- May 15(Thu)
- 13:00-14:30
- International Symposium 1_Insights from the Editorial Board: Navigating the World of Publishing in Leading Medical Journals
- Room 1 (3F)
- ENG/KOR (AI Translation)
- 13:00-13:30
- Strategies for publishing in high impact journals: The Lancet Rheumatology
- Anna Clark (The Lancet Rheumatology, UK)
- 13:30-14:00
- The distinctiveness and mission of IJRD as a leading journal in the rheumatology of the Asian-Pacific region
- James Cheng-Chung Wei (Chung Shan Medical Univ., Taiwan)
- 14:00-14:30
- Future direction of journal of rheumatic diseases
- Min-Chan Park (Yonsei Univ., Korea)
- May 15(Thu)
- 15:30-17:30
- International Joint Symposium (KCR and APLAR member)
- Room 1 (3F)
- English (AI Translation)
- Chairs
- Kichul Shin (Seoul Nat'l Univ., Korea)
- Lai-Shan Tam (The Chinese Univ. of Hong Kong, Hong Kong)
- 15:30-16:00
- Sjogren' Syndrome: New world revealed by multi-omics analysis
- Tsutomu Takeuchi (Saitama Medical Univ., Japan)
- 16:00-16:30
- Optimal application MRI in axial spondyloarthritis harnessing AI
- Ashish Mathew (Christian Medical College, Vellore, India)
- 16:30-17:00
- What’s new in Gout management?
- Nicola Dalbeth (University of Auckland, New Zealand)
- 17:00-17:30
- Unseen burden: SLE in women of childbearing age
- Jisoo Lee (Ewha Womans Univ., Korea)
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 1 [Eisai Korea Inc.]
- A Well-balanced JAKi for Patients with RA
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Bin Yoo (Univ. of Ulsan, Korea)
- 17:30-18:30
- Efficacy and safety of Jyseleca for the treatment of rheumatoid arthritis: Recent updates
- Dong-Jin Park (Chonnam Nat'l Univ., Korea)
- May 15(Thu)
- 08:00-09:00
- Breakfast Symposium 1 [Samsung Bioepis]
- Behçet Disease
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Sang-il Lee (Gyeongsang Nat'l Univ., Korea)
- 08:00-09:00
- Treatment options for Behçet's Disease: The emerging role of biologic therapies
- You-Jung Ha (Seoul Nat'l Univ., Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 2 [Abbvie]
- Unlocking the Therapeutic Potential of JAK Inhibitors in Axial Spondyloarthritis Management
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Geun Tae Kim (Kosin Univ., Korea)
- 12:00-13:00
- Comprehensive management of axial spondyloarthritis with Upadacitinib
- Yun Hong Cheon (Gyeongsang Nat'l Univ., Korea)
- May 15(Thu)
- 13:00-14:30
- Free Paper Session 1_Systemic Lupus Erythematosus and Antiphospholipid Syndrome (I)
- Room 2 (3F)
- English
- May 15(Thu)
- 15:30-16:30
- Free Paper Session 2_Systemic Lupus Erythematosus and Antiphospholipid Syndrome (II)
- Room 2 (3F)
- English
- May 15(Thu)
- 16:30-17:30
- Free Paper Session 4_Sjögren's Syndrome
- Room 2 (3F)
- English
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 2 [Astellas]
- Innovations in Lupus Nephritis Management
- Room 2 (3F)
- English (AI Translation)
- Chair
- Jung-Yoon Choe (Daegu Catholic Univ., Korea)
- 17:30-18:30
- Role of calcineurin inhibitors in the current therapeutic landscape for lupus nephritis
- Tak Mao Chan (The Univ. of Hong Kong, Hong Kong)
- May 15(Thu)
- 09:00-10:30
- Year in Review, Basic
- Room 3 (5F)
- Korean (AI Translation)
- 09:00-09:30
- Recent advances in basic research on SLE
- Seokchan Hong (Univ. of Ulsan, Korea)
- 09:30-10:00
- Recent advances in basic research on RA
- Seungwoo Han (Kyungpook Nat'l Univ., Korea)
- 10:00-10:30
- Advances in Systemic Sclerosis: Emerging pathogenic insights and breakthroughs in basic research
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
- May 15(Thu)
- 12:00-13:00
- Luncheon Symposium 3 [Pfizer & Hanlim MS]
- Beyond 10 Years Experienced JAK-i in RA, Tofacitinib
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Yun Jong Lee (Seoul Nat'l Univ., Korea)
- 12:00-13:00
- Long term strategy for the treatment of patients with RA
- Seokchan Hong (Univ. of Ulsan, Korea)
- May 15(Thu)
- 13:00-14:30
- KCR-KASID Joint Symposium
- Room 3 (5F)
- English (AI Translation)
- 13:00-13:30
- Connections between spondyloarthritis and IBD: The immunobiology link
- Tae-Jong Kim (Chonnam Nat'l Univ., Korea)
- 13:30-14:00
- GI involvement of Behcet's disease: Another subset of IBD
- Jae Hee Cheon (Yonsei Univ., Korea)
- 14:00-14:30
- New aspects of IBD treatment: From Cytokines to small molecules
- Sung Noh Hong (Sungkyunkwan Univ., Korea)
- May 15(Thu)
- 15:30-16:30
- Free Paper Session 3_Muscle Disease Including Myopathies
- Room 3 (5F)
- English
- May 15(Thu)
- 16:30-17:30
- Free Paper Session 5_Vasculitis, Systemic Sclerosis, Fibromyalgia
- Room 3 (5F)
- English
- May 15(Thu)
- 17:30-18:30
- Evening Symposium 3 [Lilly]
- Optimizing Axial Spondyloarthritis Management
- Room 3 (5F)
- English (AI Translation)
- Chair
- Tae-Hwan Kim (Hanyang Univ., Korea)
- 17:30-18:30
- Treating patients with different CRP level
- Raj Sengupta (The Royal Nat'l Hosp. for Rheumatic Diseases, Bath, UK)
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 2 [Abbvie]
- Unlocking the Therapeutic Potential of JAK Inhibitors in Rheumatoid Arthritis Management
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Sang-Heon Lee (Konkuk Univ., Korea)
- 08:00-09:00
- Persistence of remission in rheumatoid arthritis with Upadacitinib
- Yeon-Ah Lee (Kyung Hee Univ., Korea)
- May 16(Fri)
- 09:00-10:00
- Keynote Lecture 1
- Room 1 (3F)
- English (AI Translation)
- 09:00-10:00
- Multi-omics approach in rheumatology: From cells to precision medicine
- Keishi Fujio (The Univ. of Tokyo, Japan)
- May 16(Fri)
- 10:30-12:00
- International Symposium 2_Innovative Therapeutic Strategies in Axial Spondyloarthritis
- Room 1 (3F)
- English (AI Translation)
- 10:30-11:00
- Tailored therapeutic approaches for biologics and JAK inhibitors in axial spondyloarthritis
- Lianne S. Gensler (Univ. of California, San Francisco, USA)
- 11:00-11:30
- Exploring the intestinal microbiome in axial spondyloarthritis
- Francesco Ciccia (Univ. della Campania L. Vanvitelli, Italy)
- 11:30-12:00
- Optimizing biologic tapering strategies in spondyloarthritis
- Hong Ki Min (Konkuk Univ., Korea)
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 4 [Samsung Bioepis]
- Bone Disease
- Room 1 (3F)
- Korean (AI Translation)
- Chair
- Jung Soo Song (Chung-Ang Univ., Korea)
- 12:00-13:00
- The changing landscape of bone disease management & clinical insight of Denosumab biosimilar
- Jinwuk Hur (Eulji Univ., Korea)
- May 16(Fri)
- 13:00-14:30
- International Symposium 3_Geriatrics in Rheumatology: How to Optimize the Treatment for Aging Patients
- Room 1 (3F)
- English (AI Translation)
- 13:00-13:30
- The immune system's twilight: Immunosenescence and inflammaging as interconnected phenomena
- Won-Woo Lee (Seoul Nat'l Univ., Korea)
- 13:30-14:00
- Essential considerations for treating older rheumatology patients
- Una Makris (UT Southwestern Medical Center, USA)
- 14:00-14:30
- Polymyalgia rheumatica: Not an isolated disease but rather a disease spectrum
- Milena Bond (Hosp. of Brunico, Italy)
- May 16(Fri)
- 15:30-17:00
- International Symposium 4_Optimizing Treatment Strategies to Mitigate Cardiovascular Risk in Rheumatoid Arthritis Patients
- Room 1 (3F)
- English (AI Translation)
- 15:30-16:00
- Impact of disease-modifying anti-rheumatic drugs on vascular inflammation in rheumatoid arthritis patients
- Joan M Bathon (Columbia Univ., USA)
- 16:00-16:30
- Treatment approaches for elderly rheumatoid arthritis patients in Japan: A focus on cardiovascular health
- Toshihiro Nanki (Toho Univ., Japan)
- 16:30-17:00
- Current evidence on JAK inhibitors and cardiovascular risk in Korean rheumatoid arthritis patients
- Soo-Kyung Cho (Hanyang Univ., Korea)
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 3 [Celltrion]
- Efficacy of Infliximab SC in Treatment of axSpA
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Chang-Hee Suh (Ajou Univ., Korea)
- 08:00-09:00
- Real-world evidence of IFX SC in treatment of axSpA
- Sang-Hoon Lee (Kyung Hee Univ., Korea)
- May 16(Fri)
- 10:30-12:00
- Free Paper Session 6_Rheumatoid Arthritis (I)
- Room 2 (3F)
- English
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 5 [Eisai Korea Inc.]
- A Well-balanced JAKi for Patients with RA
- Room 2 (3F)
- English (AI Translation)
- Chair
- Ji Hyeon Ju (The Catholic Univ. of Korea, Korea)
- 12:00-13:00
- The role of Jyseleca in rheumatoid arthritis: Insights from the Japanese experience
- Tomohiro Koga (Nagasaki Univ., Japan)
- May 16(Fri)
- 13:00-14:30
- Free Paper Session 8_Rheumatoid Arthritis (II)
- Room 2 (3F)
- English
- May 16(Fri)
- 15:30-16:30
- Free Paper Session 9_Rheumatoid Arthritis (III)
- Room 2 (3F)
- English
- May 16(Fri)
- 16:30-17:30
- Free Paper Session 10_Spondyloarthropathy Including Psoriatic Arthritis (II)
- Room 2 (3F)
- English
- May 16(Fri)
- 08:00-09:00
- Breakfast Symposium 4 [Daewoong]
- Realizing the True Value of Biosimilars
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Seungjae Hong (Kyung Hee Univ., Korea)
- 08:00-09:00
- New era of Biosimilar in rheumatic diseases
- Eun Hye Park (Chung-Ang Univ., Korea)
- May 16(Fri)
- 10:30-12:00
- KCR-KSID Joint Symposium
- Room 3 (5F)
- English (AI Translation)
- 10:30-11:00
- Immune dysregulation and long COVID
- Sung-Han Kim (Univ. of Ulsan, Korea)
- 11:00-11:30
- Post-COVID19 autoimmune diseases; Myth or reality
- Jaehun Jung (Korea Univ., Korea)
- 11:30-12:00
- How to optimize vaccine response in patients with rheumatic diseases
- Jin Kyun Park (Seoul Nat'l Univ., Korea)
- May 16(Fri)
- 12:00-13:00
- Luncheon Symposium 6 [Novartis]
- Spotlight Secukinumab in Axial Spondyloarthritis
- Room 3 (5F)
- English (AI Translation)
- Chair
- Yong-Beom Park (Yonsei Univ., Korea)
- 12:00-13:00
- Secukinumab in axial spondyloarthritis: Advancing IL-17 inhibition for better patient outcomes
- Lianne S. Gensler (Univ. of California, San Francisco, USA)
- May 16(Fri)
- 13:00-14:30
- Free Paper Session 7_Spondyloarthropathy Including Psoriatic Arthritis (I)
- Room 3 (5F)
- English
- May 16(Fri)
- 15:30-17:30
- Health Insurance Committee Session_The Process for Insurance Coverage of Medical Procedures and Medications in the Rheumatology Field
- Room 3 (5F)
- Korean (AI Translation)
- 15:30-16:00
- The process for insurance coverage of medical procedures
- Seong-hun Jeong (Ministry of Health and Welfare, Division of Health Insurance Benefits, Korea)
- 16:00-16:30
- The process of insurance coverage for medications and unmet needs in rheumatology field
- Bo Young Yoon (Inje Univ., Korea)
- 16:30-17:30
- Panel Discussion
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 5 [Novartis]
- Revolutionizing Autoimmune Therapy
- Room 1 (3F)
- English (AI Translation)
- Chair
- Shin-Seok Lee (Chonnam Nat'l Univ., Korea)
- 08:00-09:00
- B cells at the core: Unlocking new insights in autoimmune disease
- Peter Gergely (Novartis Biomedical Research, Switzerland)
- May 17(Sat)
- 09:00-10:00
- Keynote Lecture 2
- Room 1 (3F)
- English (AI Translation)
- 09:00-10:00
- Cell therapy in rheumatic diseases
- Ji Hyeon Ju (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 11_Epidemiology & Public Health
- Room 1 (3F)
- English
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 7 [Celltrion]
- Tocilizumab Biosimilar for Rheumatoid Arthritis
- Room 1 (3F)
- English (AI Translation)
- Chair
- Seung Cheol Shim (Chungnam Nat'l Univ., Korea)
- 12:00-13:00
- CT-P47(Avtozma) clinical trial review based on efficacy and safety
- Josef S. Smolen (Medical Univ. of Vienna, Austria)
- May 17(Sat)
- 13:00-14:30
- Free Paper Session 14_Osteoarthritis, Low Back Pain, and Miscellaneous
- Room 1 (3F)
- English
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 6 [Johnson&Johnson]
- Durable AS Treatment Option, Golimumab
- Room 2 (3F)
- Korean (AI Translation)
- Chair
- Min-Chan Park (Yonsei Univ., Korea)
- 08:00-09:00
- How Golimumab shapes the future of AS patients with “Persistence”
- Seulkee Lee (Sungkyunkwan Univ., Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 12_Basic Research
- Room 2 (3F)
- English
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 8 [Boehringer Ingelheim]
- Present and Future Perspectives on CTD-ILD Management
- Room 2 (3F)
- English (AI Translation)
- Chair
- Eun Young Lee (Seoul Nat'l Univ., Korea)
- 12:00-13:00
- Guidelines for SARD-ILD and the treatment role of antifibrotic agent
- Oliver Distler (Univ. Hosp. Zurich, Switzerland)
- May 17(Sat)
- 13:00-14:30
- General Practitioners' Session
- Room 2 (3F)
- Korean (AI Translation)
- 13:00-13:30
- Learn about cardiac arrhythmias associated with rheumatic diseases
- Jae-Sun Uhm (Yonsei Univ., Korea)
- 13:30-14:00
- Stepwise approach to cytopenia - differential diagnosis with SLE
- Young Hoon Park (Ewha Womans Univ., Korea)
- 14:00-14:30
- Screening for interstitial lung disease in the general practice
- Yeon-Ah Lee (Kyung Hee Univ., Korea)
- May 17(Sat)
- 08:00-09:00
- Breakfast Symposium 7 [ChongKunDang & Amgen]
- Advancing Osteoporosis Care in Rheumatology Patients
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Yoon-Kyoung Sung (Hanyang Univ., Korea)
- 08:00-09:00
- Why Prolia? Emphasizing its originality in preventing fractures
- Sung Soo Kim (Univ. of Ulsan, Korea)
- May 17(Sat)
- 10:30-12:00
- Free Paper Session 13_Crystal Arthropathies
- Room 3 (5F)
- English
- May 17(Sat)
- 12:00-13:00
- Luncheon Symposium 9 [JW Pharmaceutical]
- Tocilizumab: Treatment of Rheumatic Diseases
- Room 3 (5F)
- Korean (AI Translation)
- Chair
- Seong-Ho Kim (Inje Univ., Korea)
- 12:00-13:00
- The role of Tocilizumab in RA and JIA treatment
- Jennifer Jooha Lee (The Catholic Univ. of Korea, Korea)
- May 17(Sat)
- 13:00-14:30
- KCR-KCPCI Joint Symposium_Adult and Pediatric Rheumatic Diseases
- Room 3 (5F)
- English (AI Translation)
- 13:00-13:30
- Treatment Patterns in Juvenile Idiopathic Arthritis in Korea
- Dae-Chul Jeong (The Catholic Univ. of Korea, Korea)
- 13:30-14:00
- Role of inflammatory cytokines and cytokine-targeted therapy in systemic JIA and MAS
- Masaki Shimizu (Institute of Science Tokyo, Japan)
- 14:00-14:30
- bDMARDs and tsDMARDs for adult and pediatric rheumatic diseases
- Su-Jin Moon (The Catholic Univ. of Korea, Korea)
